Bakhla Ajay Kumar, Gore Prakash S, Srivastava Sanjay Lal
Department of Psychiatry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
DNB Trainee, Department of Medicine, Tata Motors Hospital, Jamshedpur, Jharkhand, India.
Ind Psychiatry J. 2013 Jan;22(1):69-70. doi: 10.4103/0972-6748.123636.
We report a 21-year-old male who developed manic symptoms after addition of second line anti-tuberculosis treatment for his multidrug resistant tuberculosis. We identified cycloserine as offending drug; and discuss the management and possible neurobiological mechanisms as etiological explanation and implications of manic switch caused by cycloserine.
我们报告了一名21岁男性,他在接受二线抗结核治疗以应对耐多药结核病后出现了躁狂症状。我们确定环丝氨酸为致病药物;并讨论了其管理以及作为环丝氨酸所致躁狂转换病因解释的可能神经生物学机制和影响。